Results 261 to 270 of about 9,662,184 (369)

Switching disease‐modifying therapies in patients with spinal muscular atrophy: A systematic review on effectiveness outcomes

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
With multiple disease‐modifying therapies now available, treatment switching has become an important clinical consideration in the management of spinal muscular atrophy (SMA). While some switches are prompted by suboptimal clinical response, more commonly they are driven by treatment burden, convenience, or adverse events.
Andrej Belančić   +4 more
wiley   +1 more source

Undetected Neuromuscular Disease in Patients after Heart Transplantation. [PDF]

open access: yesInt J Mol Sci
Bekele BM   +9 more
europepmc   +1 more source

Optimizing biophysical properties of cellular niches to enhance stem cell‐derived extracellular vesicle function in musculoskeletal regeneration

open access: yesBMEMat, EarlyView.
Extracellular vesicles (EVs) derived from stem cells show promise for applications in regenerative medicine, but their scalability and yield remain challenges. This review explores the approaches for biophysical modulations within cell niches on EV properties, discusses the current clinical application of EVs, and provides an outlook on the existing ...
Yang Xu   +9 more
wiley   +1 more source

Medium-term immunogenicity of three doses of BNT162b2 and CoronaVac in Hong Kong neuromuscular disease patients. [PDF]

open access: yesHum Vaccin Immunother
Yu MKL   +11 more
europepmc   +1 more source

8. Neuromuscular Diseases

open access: bronze, 2008
Tadashi Kanouchi, Hidehiro Mizusawa
openalex   +2 more sources

Functional Connectivity under Optogenetic Control Allows Modeling of Human Neuromuscular Disease.

open access: yesCell Stem Cell, 2016
Julius A. Steinbeck   +7 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy